Posted: May 8, 2012 9:02 AM by Associated Press
WASHINGTON (AP) - Federal drug regulators are affirming that a landmark study showing that a popular HIV-fighting pill already on the market can also help people avoid contracting the virus that causes AIDS in the first place.
The Food and Drug Administration will hold a meeting Thursday to discuss whether Truvada should be approved for people who are at risks of contracting HIV through sexual intercourse. The agency's positive review suggests the daily pill will become the first drug approved to prevent HIV infection in high-risk patients.
FDA reviewers conclude that using Truvada pre-emptively could spare patients "infection with a serious and life-threatening illness that requires lifelong treatment."
Reviewers stressed that the drug only works when taken daily by patients, and that patients may often forget to take the medication.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at firstname.lastname@example.org, and include the name of the story and information on the comment.
Thank you! KSBY.com
Get deals up to 80% off here!
Find the lowest gas prices in your area
Submit your photos to KSBY
Check out our calendar of events
Save with Hot Deals across our counties!
Events across the Central Coast
Follow The CW5 on Facebook.
The KSBY online public file.
What do you think? Leave us your feedback.
KSBY is your official CA Lottery station for San Luis Obispo and Santa Barbara Counties